001     280965
005     20250921002013.0
024 7 _ |a 10.1161/CIRCULATIONAHA.124.073181
|2 doi
024 7 _ |a pmid:40654086
|2 pmid
024 7 _ |a pmc:PMC12262172
|2 pmc
024 7 _ |a 0009-7322
|2 ISSN
024 7 _ |a 0065-8499
|2 ISSN
024 7 _ |a 1524-4539
|2 ISSN
024 7 _ |a altmetric:179880991
|2 altmetric
037 _ _ |a DZNE-2025-01047
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Carbonneau, Madeleine
|0 0009-0002-4102-5952
|b 0
245 _ _ |a DNA Methylation Signatures of Cardiovascular Health Provide Insights Into Diseases.
260 _ _ |a Philadelphia, Pa.
|c 2025
|b Lippincott, Williams & Wilkins
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1758106149_31851
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The association of overall cardiovascular health (CVH) with changes in DNA methylation (DNAm) has not been well characterized.We calculated the American Heart Association's Life's Essential 8 score to reflect CVH in 5 cohorts with diverse backgrounds (mean age 54 years, 55% women, and enrollment year ranging from 1989 to 2012). Epigenome-wide association studies (EWAS) for Life's Essential 8 score were conducted, followed by bioinformatic analyses. DNAm loci significantly associated with Life's Essential 8 score were used to calculate a CVH DNAm score. We examined the association of the CVH DNAm score with incident cardiovascular disease (CVD), cardiovascular disease-specific mortality, and all-cause mortality.We identified 609 cytosine-phosphate-guanines (CpGs) associated with Life's Essential 8 score at false discovery rate<0.05 in the discovery analysis and at Bonferroni-corrected P<0.05 in the multicohort replication stage. Most had low to moderate heterogeneity (414 CpGs [68.0%] with heterogeneity <0.2) in replication analysis. Pathway enrichment analyses and a phenome-wide association study search associated these CpGs with inflammatory or autoimmune phenotypes. We observed enrichment for phenotypes in the Epigenome-Wide Association Study Catalog, with 29-fold enrichment for stroke (P=2.4e-15) and 21-fold for ischemic heart disease (P=7.4e-38). Two-sample Mendelian randomization (MR) analysis showed significant association between 141 CpGs and ten phenotypes (261 CpG-phenotype pairs) at false discovery rate<0.05. For example, hypomethylation at cg20544516 (MIR33B [microRNA 33b] and SREBF1 [sterol regulatory element-binding transcription factor 1]) is associated with a lower risk of stroke (P=8.1e-6). In multivariable prospective analyses, the CVH DNAm score was consistently associated with clinical outcomes across participating cohorts. Per SD increase in the CVH DNAm score, the decrease in risk of incident cardiovascular disease, cardiovascular disease mortality, and all-cause mortality ranged from 19% to 32%, 28% to 40%, and 27% to 45%, respectively.We identified new DNAm signatures for CVH across diverse cohorts. Our analyses indicate that multiple biological pathways may be relevant to the observed association between CVH and clinical outcomes.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a DNA methylation
|2 Other
650 _ 7 |a Life’s Essential 8
|2 Other
650 _ 7 |a all-cause mortality
|2 Other
650 _ 7 |a cardiovascular diseases
|2 Other
650 _ 7 |a cardiovascular health
|2 Other
650 _ 7 |a epigenome-wide association study
|2 Other
700 1 _ |a Li, Yi
|0 0000-0002-5544-750X
|b 1
700 1 _ |a Qu, Yishu
|0 0000-0001-5937-3811
|b 2
700 1 _ |a Zheng, Yinan
|0 0000-0002-2006-7320
|b 3
700 1 _ |a Wood, Alexis C
|0 0000-0001-7616-2119
|b 4
700 1 _ |a Wang, Mengyao
|b 5
700 1 _ |a Liu, Chunyu
|0 0000-0002-9160-0153
|b 6
700 1 _ |a Huan, Tianxiao
|b 7
700 1 _ |a Joehanes, Roby
|0 0000-0001-5549-9054
|b 8
700 1 _ |a Guo, Xiuqing
|0 0000-0002-5264-5068
|b 9
700 1 _ |a Yao, Jie
|0 0000-0002-8822-0651
|b 10
700 1 _ |a Taylor, Kent D
|0 0000-0002-2756-4370
|b 11
700 1 _ |a Tracy, Russell P
|0 0000-0002-0080-2420
|b 12
700 1 _ |a Durda, Peter
|0 0000-0003-4000-2943
|b 13
700 1 _ |a Liu, Yongmei
|0 0000-0002-6562-1858
|b 14
700 1 _ |a Johnson, W Craig
|0 0000-0002-3161-3753
|b 15
700 1 _ |a Post, Wendy S
|0 0000-0002-8655-5204
|b 16
700 1 _ |a Blackwell, Tom
|b 17
700 1 _ |a Rotter, Jerome I
|0 0000-0001-7191-1723
|b 18
700 1 _ |a Rich, Stephen S
|0 0000-0003-3872-7793
|b 19
700 1 _ |a Redline, Susan
|0 0000-0002-6585-1610
|b 20
700 1 _ |a Fornage, Myriam
|0 0000-0003-0677-8158
|b 21
700 1 _ |a Wang, Jun
|b 22
700 1 _ |a Ning, Hongyan
|0 0000-0003-1157-6614
|b 23
700 1 _ |a Hou, Lifang
|0 0000-0003-4877-0031
|b 24
700 1 _ |a Lloyd-Jones, Donald
|0 0000-0003-0847-6110
|b 25
700 1 _ |a Ferrier, Kendra
|0 0000-0002-8813-6871
|b 26
700 1 _ |a Min, Yuan-I
|0 0000-0003-2470-0004
|b 27
700 1 _ |a Carson, April P
|0 0000-0002-7970-6756
|b 28
700 1 _ |a Raffield, Laura M
|0 0000-0002-7892-193X
|b 29
700 1 _ |a Teumer, Alexander
|0 0000-0002-8309-094X
|b 30
700 1 _ |a Grabe, Hans J
|0 P:(DE-2719)2811781
|b 31
700 1 _ |a Völzke, Henry
|b 32
700 1 _ |a Nauck, Matthias
|0 0000-0002-6678-7964
|b 33
700 1 _ |a Dörr, Marcus
|0 0000-0001-7471-475X
|b 34
700 1 _ |a Domingo-Relloso, Arce
|0 0000-0001-6928-8290
|b 35
700 1 _ |a Fretts, Amanda
|0 0000-0002-5358-2345
|b 36
700 1 _ |a Tellez-Plaza, Maria
|0 0000-0002-3850-1228
|b 37
700 1 _ |a Cole, Shelley A
|0 0000-0002-2651-0127
|b 38
700 1 _ |a Navas-Acien, Ana
|0 0000-0001-9824-7797
|b 39
700 1 _ |a Wang, Meng
|0 0000-0001-8345-9180
|b 40
700 1 _ |a Murabito, Joanne M
|0 0000-0002-0192-7516
|b 41
700 1 _ |a Heard-Costa, Nancy L
|0 0000-0001-9730-0306
|b 42
700 1 _ |a Prescott, Brenton
|0 0000-0002-3805-9070
|b 43
700 1 _ |a Xanthakis, Vanessa
|0 0000-0002-7352-621X
|b 44
700 1 _ |a Mozaffarian, Dariush
|0 0000-0001-7958-9492
|b 45
700 1 _ |a Levy, Daniel
|0 0000-0003-1843-8724
|b 46
700 1 _ |a Ma, Jiantao
|0 0000-0001-7478-7203
|b 47
773 _ _ |a 10.1161/CIRCULATIONAHA.124.073181
|g Vol. 152, no. 7, p. 436 - 449
|0 PERI:(DE-600)1466401-X
|n 7
|p 436 - 449
|t Circulation
|v 152
|y 2025
|x 0009-7322
909 C O |o oai:pub.dzne.de:280965
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 31
|6 P:(DE-2719)2811781
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a Allianz-Lizenz
|0 StatID:(DE-HGF)0410
|2 StatID
|d 2024-12-16
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-16
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-16
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CIRCULATION : 2022
|d 2024-12-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-16
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-16
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b CIRCULATION : 2022
|d 2024-12-16
920 1 _ |0 I:(DE-2719)5000001
|k AG Grabe
|l Biomarkers of Dementia in the General Population
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)5000001
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21